Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000186709 | SCV000240275 | likely pathogenic | not provided | 2024-04-26 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 33648541) |
Labcorp Genetics |
RCV001036968 | SCV001200359 | pathogenic | Adenylosuccinate lyase deficiency | 2024-10-23 | criteria provided, single submitter | clinical testing | This variant, c.1343_1345del, results in the deletion of 1 amino acid(s) of the ADSL protein (p.Ser448del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs766428638, gnomAD 0.02%). This variant has been observed in individual(s) with adenylosuccinate lyase deficiency (PMID: 33648541). ClinVar contains an entry for this variant (Variation ID: 204813). This variant disrupts a region of the ADSL protein in which other variant(s) (p.Ser448Pro) have been determined to be pathogenic (PMID: 16839792, 24781210; internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |